[REGN] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 36.56%
YoY- 93.96%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 2,936,200 2,857,200 2,965,100 4,951,700 3,452,800 5,138,500 2,528,700 10.46%
PBT 1,509,800 963,200 1,061,100 2,503,400 1,816,600 3,752,800 1,253,000 13.22%
Tax 194,100 111,100 87,600 274,400 184,400 653,900 137,800 25.63%
NP 1,315,700 852,100 973,500 2,229,000 1,632,200 3,098,900 1,115,200 11.64%
Tax Rate -12.86% -11.53% -8.26% -10.96% -10.15% -17.42% -11.00% -
Total Cost 1,620,500 2,005,100 1,991,600 2,722,700 1,820,600 2,039,600 1,413,500 9.52%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 44.81 29.82 32.83 45.01 47.27 60.31 44.10 1.06%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS 11.66 7.47 8.61 20.99 15.37 29.51 10.58 6.68%
EPS Diluted 11.66 7.47 8.61 19.69 14.33 27.97 10.09 10.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.